Hepatic Impairment
Showing NaN - NaN of 13
Prevention of Thromboembolic Events, Atrial Fibrillation, Acute Myocardial Infarction Trial in Kiel (Asundexian (BAY2433334))
Recruiting
- Prevention of Thromboembolic Events
- +4 more
- Asundexian (BAY2433334)
-
Kiel, Schleswig-Holstein, GermanyCRS-Kiel
Jan 17, 2023
Hepatic Impairment Trial in Kiel (M2951 (BTK inhibitor))
Completed
- Hepatic Impairment
- M2951 (BTK inhibitor)
-
Kiel, GermanyCRS Clinical Research Services Kiel GmbH
Jul 9, 2021
Healthy Subjects, Hepatic Impairment Trial in Kiel (Selatogrel)
Completed
- Healthy Subjects
- Hepatic Impairment
-
Kiel, GermanyCRS Clinical Research Services
Nov 4, 2020
Hepatic Impairment Trial in Kiel (JNJ-73763989)
Completed
- Hepatic Impairment
-
Kiel, GermanyCRS Clinical Research Services Kiel GmbH
Sep 29, 2020
Hepatic Impairment Trial in Kiel (Gemigliptin)
Completed
- Hepatic Impairment
-
Kiel, Schleswig-Holstein, GermanyCRS Clinical Research Services
Jul 10, 2014
Hepatic Impairment Trial in Kiel (safinamide)
Completed
- Hepatic Impairment
-
Kiel, GermanyCRS Clinical Research Services Kiel GmbH
Mar 27, 2013